Heart Failure as a Risk Factor for Osteoporosis and Fractures

被引:0
作者
Aloice O. Aluoch
Ryan Jessee
Hani Habal
Melinda Garcia-Rosell
Rehan Shah
Guy Reed
Laura Carbone
机构
[1] University of TN Health Science Center,Department of Medicine
[2] University of TN Health Science Center,Department of Medicine, Division of Rheumatology
[3] University of TN Health Science Center,Department of Medicine, Division of Cardiology
[4] Veterans Affairs Medical Center,undefined
来源
Current Osteoporosis Reports | 2012年 / 10卷
关键词
Heart failure; Osteoporosis; Fractures; Hypovitaminosis D; Renal disease; Diabetes; Spironolactone; Thiazide diuretics; Nitric oxide donors; Aspirin; Loop diuretics; Renin-angiotensin-aldosterone system; Parathyroid hormone levels; Oxidative/nitrosative stress;
D O I
暂无
中图分类号
学科分类号
摘要
Although heart failure (HF) and osteoporosis are common diseases, particularly in elderly populations, patients with HF have an increased risk for osteoporosis. The relationship of HF with osteoporosis is modified by gender and the severity of HF. In addition, shared risk factors, medication use, and common pathogenic mechanisms affect both HF and osteoporosis. Shared risk factors for these 2 conditions include advanced age, hypovitaminosis D, renal disease, and diabetes mellitus. Medications used to treat HF, including spironolactone, thiazide diuretics, nitric oxide donors, and aspirin, may protect against osteoporosis. In contrast, loop diuretics may make osteoporosis worse. HF and osteoporosis appear to share common pathogenic mechanisms, including activation of the renin-angiotensin-aldosterone system, increased parathyroid hormone levels, and/or oxidative/nitrosative stress. HF is a major risk factor for mortality following fractures. Thus, in HF patients, it is important to carefully assess osteoporosis and take measures to reduce the risk of osteoporotic fractures.
引用
收藏
页码:258 / 269
页数:11
相关论文
共 698 条
[1]  
Schocken DD(1992)Prevalence and mortality rate of congestive heart failure in the United States J Am Coll Cardiol 2 301-6
[2]  
Arrieta MI(2006)Assessment of the prevalence and costs of osteoporosis treatment options in a real-world setting Am J Manag Care 7 191-8
[3]  
Leaverton PE(2011)Osteoporosis update J Midwifery Wom Health 6 615-27
[4]  
Ross EA(2012)Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008 Osteoporos Int 3 829-39
[5]  
Brixner D(2010)Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure J Am Coll Cardiol 55 283-93
[6]  
Schuiling KD(2007)Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025 J Bone Miner Res 22 465-75
[7]  
Robinia K(2011)Change in comorbidity prevalence with advancing age among persons with heart failure J Gen Intern Med 26 1145-51
[8]  
Nye R(2005)Osteoporosis and fracture risk in women of different ethnic groups J Bone Miner Res 20 185-94
[9]  
Lippuner K(2008)Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative Hormone Intervention Trials J Bone Miner Res 23 1935-45
[10]  
Grifone S(2010)Relation between obesity and bone mineral density and vertebral fractures in Korean postmenopausal women Yonsei Med J 51 857-63